Frontlight ResearchEarly access
CompletedPhase 1
A trial of prednisolone in combination with SPI-62 in participants with polymyalgia rheumatica (PMR)
Key facts
- Who runs it
- Sparrow Pharmaceuticals Inc.
- Where
- Germany5 sites in 1 countryChoose a country to see its sites
- Trial code
- EU 2023-507721-41-00
- U1111-1296-6448
- Status
- Completed
- Phase
- Phase 1
- People taking part
- 14 people enrolled
- Started
- 11 Mar 2024
- Ended
- 3 Dec 2024
- Type of study
- Interventional
- Record updated
- 19 April 2024
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on the EU's official list of trials (CTIS).How to verify a trial in the registry
- Record updated
- 19 April 2024